Market Overview

TOX PRESSOTECHNIK to Exhibit at Fabtech 2012 in Las Vegas

Share:

Leading Hydraulic Press Manufacturer to Attend North America's Largest Metal Forming, Fabricating, Welding, and Finishing Event

Warrenville, IL (PRWEB) October 31, 2012

TOX PRESSOTECHNIK will be exhibiting at Fabtech, the largest metal forming, fabricating, welding and finishing event in North America. Fabtech will be held this year in Las Vegas at the Las Vegas Convention Center November 12-14.

TOX will be exhibiting in the following categories: assembly, bending/forming, fastening & joining, software & machine controls, stamping and tube & pipe fabricating.

“The most rewarding aspect of any tradeshow is the personal contact with attendees,” Bruno Maczynski, TOX marketing manager, said. “TOX places a great deal of emphasis on our relationship with our customers.” TOX has been exhibiting at trade shows like Fabtech for the past 26 years, he said.

“One of the most important reasons for TOX in attending tradeshows is to maintain presence with existing customers and to establish new relationships with those customers and potential new customers,” Maczynski said.

You can receive more information on the services and products TOX provides by visiting the TOX booth--#C5024 at the convention.

About TOX

TOX is the market leader in press drives, presses and sheet metal joining techniques and are known for their quality of service and products. TOX has a sales presence in 37 countries and their cultural diversity of their associates and business partners is the driving force for the continuous improvement of their performance.

All of TOX's products and processes are continuously evaluated and further developed with regards to quality, efficiency and governmental regulations. Their organizational procedures are checked and meet all international standards for quality management. Contact a TOX representative today for more information on our products or services.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10075055.htm

View Comments and Join the Discussion!